If we remove the 35 cases with family history and/or bilateral breast cancers from the analysis, a total of 15 (24.6%) BRCA1/2 mutations were identified in the remaining 61 patients of unselected triple-negative breast cancer. This evidence concerns the gene BRCA1 and breast cancer.